Biofrontera (NASDAQ:BFRI) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.20 by 146.15 percent. This is a 352.63 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $17.100 million which beat the analyst consensus estimate of $16.146 million by 5.91 percent. This is a 36.15 percent increase over sales of $12.560 million the same period last year.